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Abstract
Background: Alternative splicing of the locus AβH-J-J generates functionally distinct proteins: the enzyme
aspartyl (asparaginyl) β-hydroxylase (AAH), truncated homologs of AAH with a role in calcium homeostasis
humbug and junctate and a structural protein of the sarcoplasmic reticulum membranes junctin. AAH and humbug
are over expressed in a broad range of malignant neoplasms. We have previously reported that this locus contains
two promoters, P1 and P2. While AAH and humbug are expressed in most tissues under the regulation of the P1
promoter, AAH, junctin and junctate are predominantly expressed in excitable tissues under the control of the
P2 promoter. We previously demonstrated that Sp transcription factors positively regulate the P1 promoter.
Results: In the present study, we extended the functional characterization of the P1 promoter of the AβH-J-J
locus. We demonstrated by quantitative Real-time RT-PCR that mRNAs from the P1 promoter are actively
transcribed in all the human cell lines analysed. To investigate the transcription mechanism we transiently
transfected HeLa cells with sequentially deleted reporter constructs containing different regions of the -661/+81
P1 nucleotide sequence. Our results showed that (i) this promoter fragment is a powerful activator of the
reporter gene in HeLa cell line, (ii) the region spanning 512 bp upstream of the transcription start site exhibits
maximal level of transcriptional activity, (iii) progressive deletions from -512 gradually reduce reporter
expression.
The region responsible for maximal transcription contains an E-box site; we characterized the molecular
interactions between USF1/2 with this E-box element by electrophoretic mobility shift assay and supershift
analysis. In addition, our USF1 and USF2 chromatin immunoprecipitation results demonstrate that these
transcription factors bind the P1 promoter in vivo.
A functional role of USF1/USF2 in upregulating P1-directed transcription was demonstrated by analysis of the
effects of (i) in vitro mutagenesis of the P1/E-box binding site, (ii) RNA interference targeting USF1 transcripts.
Conclusion: Our results suggest that USF factors positively regulate the core of P1 promoter, and, together with
our previously data, we can conclude that both Sp and USF DNA interaction and transcription activity are
involved in the P1 promoter dependent expression of AAH and humbug.
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Background
We have previously characterized the human AβH-J-J
locus, a genomic sequence which generates functionally
distinct proteins [1], including the enzyme aspartyl
(asparaginyl) β-hydroxylase (AAH), junctin, a structural
protein of sarcoplasmic reticulum, humbug and junctate,
the truncated homologs of AAH calcium binding proteins
[1,2]. AAH catalyzes posttranslational hydroxylation of
aspartate and asparagine residues in certain epidermal
growth factor-like domains present in a number of pro-
teins, such as receptors and receptor ligands, involved in
cell growth and differentiation, and extracellular matrix
molecules [3]. AAH, mediates cell motility and invasive-
ness, an effect which is of interest because of its role in pla-
cental implantation and "receptivity" of endometrium
[4]. Humbug is a truncated homolog of AAH that lacks a
catalytic domain. Overexpression of humbug increases
intracellular calcium levels by promoting its release from
intracellular stores [5]. The levels of humbug immunore-
activity are directly associated with colon cancer tumor
grade and inversely associated with patient survival [6].
AAH and/or humbug are over expressed in infiltrative int-
rahepatic cholangiocarcinomas, metastasized lung,
breast, colon, hepatocellular carcinomas, and malignant
neuroectodermal tumors [7-11]. These proteins can con-
tribute to the malignant phenotype by increasing motility
and enhancing proliferation, survival, and cell cycle pro-
gression. Inhibition of AAH and humbug expression
could represent an attractive approach for gene therapy of
infiltrating tumors [3,11].
Junctate is an integral calcium binding protein of
sarco(endo)plasmic reticulum membrane, which forms a
supramolecular complex with the inositol 1,4,5 trisphos-
phate receptor and modulates calcium entry through
receptor- and store-activated channels [1,12,13].
Our group previously reported the identification of two
promoter sequences, present within the human AβH-J-J
locus (named P1 and P2), that are expected to regulate the
transcription of this locus [1,14,15]. The generated pri-
mary transcripts undergo alternative splicing and direct
the synthesis of AAH, humbug, junctin, and junctate. We
have previously reported the characterization of the P2
promoter, demonstrating that the myocyte enhancer fac-
tor 2 (MEF-2) transcription factor binds to this promoter
sequence and drives tissue-specific expression, being
responsible of inducing transcription during muscle dif-
ferentiation [14,15].
In additon, we have recently reported the role of Sp factors
in upregulating the P1-directed transcription of the AβH-
J-J locus [16]. This was the first study about the role of the
P1 promoter.
In the present study we focused our attention on the role
of another putative regulating sequence, namely an E-box,
which is located in the region of the P1 promoter and is
required for high-level of transcription.
To characterize the expression directed by the P1 pro-
moter, we have analysed the corresponding mRNAs in dif-
ferent cell lines. Furthermore, transfections of HeLa cells
with progressively deleted reporter constructs of the -661/
+81 P1 promoter region were performed and the tran-
scription activity of each fragment was characterized.
DNA/transcription factor interaction studies were per-
formed in vitro by EMSA or supershift assays, and in intact
cells by chromatin immunoprecipitations. Functional
assays were performed by in vitro mutagenesis of the E-box
binding site and by RNA interference targeting USF1 [17].
Results
Structure of the 5' end of the AβH-J-J locus
Figure 1 shows the structure of the 5' end of the human
AβH-J-J locus and the transcripts for AAH, humbug, junc-
tate and junctin, with the location of the P1 and P2 pro-
moters. Figure 2 shows the quantitative Real-time RT-PCR
analysis of the transcripts starting from P1 promoter in a
panel of human cell lines. In this experiment cDNA
derived from MCF7, Colo 38, Hek293, HepG2, HeLa, RD
and MDA human cell lines were employed. The results
obtained indicate that the P1 promoter directs transcrip-
tion in all the cell lines analysed and is more active in
HeLa cells (Figure 2, column e). These data confirm and
further extend the concept that P1 promoter, unlike the
tissue-specific P2 promoter, directs transcription in cells
of different tissues, as recently reported by our research
group [15,16].
Identification of functional region within the AβH-J-J P1 
promoter
In order to identify putative regulatory regions located
within AβH-J-J P1 promoter, HeLa cells were transiently
transfected with sequentially deleted reporter constructs,
containing different regions of the -661/+81 P1 nucle-
otide sequence cloned into pGL3-basic reporter vector
[16].
The data of transient transfection and luciferase assays
were normalized to renilla luciferase activity. An addi-
tional comparison was done with the pGL3-basic reporter
vector. The results represented in Fig 3 demonstrate that:
i) the -661/+81 promoter region exhibits high reporter
gene expression in HeLa cells; ii) luciferase activity is
higher with the reporter construct lacking the -634/-512
sequence, suggesting the presence in this region of cis-act-
ing elements inhibiting transcription; iii) the expression
of the reporter gradually decreases when the sequence
from -512 to -160 is progressively removed. These resultsBMC Molecular Biology 2008, 9:110 http://www.biomedcentral.com/1471-2199/9/110
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clearly demonstrate that the maximal luciferase activity is
dependent on the -512/+81 sequence (Figure 3H con-
struct), indicating the presence within this region of posi-
tive regulatory elements, responsible for the maximum
level of transcription activity. In order to identify putative
binding sites for transcription factors, computer-assisted
analysis of the sequences was performed. The -512/+1
region displays sequence homology to the following tran-
scription factor binding sites: USF1 (98%, Fig 4), AP-1
(88%), GATA-1/3 (90–85%), NF-E2 (91%) and Sp1 (98–
81%). We have previously reported the interaction of Sp
transcription factors to P1 promoter [16]; we therefore
analyzed the other putative binding sites by EMSA, dem-
onstrating that only the USF1 element is able to bind
nuclear extracts.
In vitro and in vivo Interaction of USF1 and USF2 
transcription factors with the AβH-J-J P1 promoter
To determine whether the E-box site is able to interact
with USF1 and USF2 transcription factors, EMSA experi-
ments were carried out using 2 μg of HeLa nuclear extracts
and the P1/USFmer probe (Table 1). The results obtained
are reported in Figure 5 and indicate that the P1/USFmer
probe stably interacts with nuclear extracts, forming the
complexes shown in figure 5A (lane 1, arrows). As
expected, P1/USFmer and consensus USFmer probes effi-
ciently compete with the binding (Figure 5A, lanes 2, 3),
while Sp1mer and MyoDmer probes do not (Figure 5A,
lanes 4, 5). In order to demonstrate the presence of USF1
and USF2 transcription factors in the retarded complexes,
supershift analyses were performed. We incubated P1/
USFmer probe and 2 μg of nuclear extract from HeLa cells
with antibodies against USF1, USF2 or both factors (Fig-
ure 5B, lanes 7, 8 and 9 respectively). Our results indicate
that both antibodies induce a supershift of the retarded
bands. These data conclusively demonstrate that both
USF1 and USF2 are able to bind to the P1/USFmer probe
in vitro.
Structure of the 5' end of the human locus for AAH, humbug, junctate, and junctin Figure 1
Structure of the 5' end of the human locus for AAH, humbug, junctate, and junctin. Arabic numbers over black 
boxes indicate exons. Intervening sequences are indicated in Roman numbers. The two putative promoters P1 and P2 are indi-
cated. A schematic representation of AAH, humbug, junctate and junctin exons splicing is reported at the bottom of the panel. 
The cytoplasmic, TM, positively charged, calcium-binding, and catalytic domains are indicated. The locations of AUG, stop 
codons, and poly(A) signals are shown.
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In order to verify whether USF1/2 and P1 promoter inter-
act in vivo, chromatin immunoprecipitation (ChIP)
assays were performed on HeLa cells. Chromatin was
immunoprecipitated using either USF1 and USF2 antise-
rum and quantitative amplification of P1 promoter was
performed on purified DNA. A representative ChIP assay
(Figure 6A) shows that amplification curves from samples
immunoprecipitated with USF1 or USF2 antisera reach
threshold 10 cycles early than those treated with MEF-2
antiserum or non immune serum. In figure 6B ChIP
Quantitative Real-time RT-PCR analysis of the transcripts starting from P1 promoter in human cell lines Figure 2
Quantitative Real-time RT-PCR analysis of the transcripts starting from P1 promoter in human cell lines. (A) 
The exon 1 starting mRNAs of AAH and humbug, the PCR primers and the 297 bp PCR product are represented; white boxes 
indicate exons common to the two transcripts. (B) Relative mRNA expression levels of P1 promoter transcripts were evalu-
ated by Quantitative real-time RT-PCR in which cDNA derived from human cell lines (a, MCF7; b, Colo 38; c, Hek293; d, 
HepG2; e, HeLa; f, RD; g, MDA) total RNA were amplified. Relative quantification is expressed as normalized fold expression 
and was calculated by using MCF7 as reference sample (value = 1). All data represent the mean of three determinations from 
two independent experiments; *P < 0.001.
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results are reported as immunospecific fold enrichment in
P1 promoter sequences relative to a negative control
sequence that lacks USF1 binding sites. The data supports
the in vivo interaction between USF1 and USF2 and the
P1 promoter in intact cells.
Mutation of the USF element of the AβH-J-J P1 promoter: 
effects on transcription
Figure 7A–B shows the effect of the mutation of the P1/
USFmer probe on its ability to bind nuclear factors. 32P-
labelled P1/USFmer (Figure 7A) or USFmer (Figure 7B)
probes were incubated with HeLa cell nuclear extract in
the absence or in the presence of 100 fold molar excess of
competing wild type or mutant (P1/USFmut) oligonucle-
otides (see Table 1 for nucleotide sequences). The data
obtained demonstrate that the mutations fully suppress
the ability of the probes to bind nuclear factors (Figure 7A,
lane 2 and Figure 7B, lane 5). The effect of this mutation
on the transcription activity are shown in Figure 7C. The
reporter construct -512/+81 (H in Fig 3) was subjected to
site directed mutagenesis in the sequence spanning Sp1
and USF1 binding sites (constructs -512 P1/Spmut and -
512 P1/USFmut). In addition a double mutant containing
both mutations was generated (-512 P1/Sp+USFmut).
HeLa cells were transfected with wild type -512/+81 (-512
WT), single or double mutant AβH-J-J P1 promoter
reporter constructs. Comparison of reporter expression in
HeLa extracts shows that the mutation in the USF binding
site significantly inhibits transcription directed by the -
512 construct (Figure 7C). This effect is further enhanced
when the -512 P1/Sp+USFmut double mutant construct is
employed. These data strongly suggest that interaction of
nuclear factors to the USF binding site is required for max-
imum level of P1 promoter transcription.
Effect on P1 promoter activity of USF1 silencing obtained 
by RNA interference
In order to demonstrate the role of proteins belonging to
the USF family on the transcription directed by the P1
promoter of the human AβH-J-J locus, silencing of the
USF1 gene was performed using short interfering RNAs. A
double stranded oligonucleotide, targeting human USF1
RNA sequence, or a scrambled sequence (Table 2), which
has no significant homology to human genes and tran-
scripts, were cloned into pSingle-tTS-shRNA plasmid.
HeLa cells were then transiently transfected with USF1
shRNA vector. To detect non-specific effects, scramble
shRNA vector and construct lacking small hairpin DNA
(Null shRNA) were used as controls. Two days after trans-
fection, total RNA was extracted and used for quantitative
Real Time RT-PCR, using primers targeting USF1 mRNA
or P1 promoter specific transcripts. Figure 8A shows that
USF1 mRNA levels are strongly reduced following trans-
fection with USF1 shRNA vector. In addition Figure 8B
shows that USF1 depletion was associated with inhibition
of the P1 directed transcription. The effects of null shRNA
and scramble shRNA vectors were much lower or absent
on USF1 mRNA levels (Figure 8A) and P1 directed tran-
scription (Figure 8B) respectively.
AβH-J-J P1 promoter activity in HeLa cell line Figure 3
AβH-J-J P1 promoter activity in HeLa cell line. HeLa cells were transiently transfected with sequentially deleted 
reporter constructs of the -661/+81 P1 nucleotide sequence (represented in the left side of the figure, F-M). Transient trans-
fection and luciferase assays were performed in triplicate, and the data (right side of the figure) were normalized to renilla luci-
ferase activity and are shown as relative activities compared to that for pGL3-basic, a reporter vector with a basal promoter. 
The values are the means ± SD of at least three independent experiments.
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Discussion
The aim of the present paper is to investigate in detail one
of the two promoter sequences regulating the transcrip-
tion of the AβH-J-J locus [14,15]. We isolated and identi-
fied the 5'-flanking region of the exon 1 of this locus. The
cloned nucleotide sequence allowed us to characterize the
P1 promoter region, which is involved in the regulation of
AAH and humbug expression. We have been able to iden-
tify transcripts relative to P1 promoter activity in all tis-
sues and cell lines analyzed [15,16]. Similar to many
housekeeping gene promoters, the region under investiga-
tion lacks a TATA box and an initiator element [18]. In
contrast, this sequence is GC-rich and presents homolo-
gies with Sp1 consensus binding site, which we previously
demonstrated to play a role in transcription [16]. Trans-
fection experiments with progressively deleted P1 pro-
moter reporter constructs in HeLa cells showed that
maximal promoter activity is located within 512 nucle-
otides from the principal transcription initiation site (see
Figures 3), a result which confirms our previous data in
HepG2 and RD cell lines [16]. Computer-assisted analysis
of the -512/+1 region indicates the presence of sequence
DNA sequence of the AβH-J-J P1 promoter region Figure 4
DNA sequence of the AβH-J-J P1 promoter region. (A) -512/+112 P1 promoter and 5' UTR sequences. Solid line indi-
cate the oligonucleotide used in EMSA (Table 1). Sequence homologies to USF and Sp1 transcription factor binding site are 
boxed; the percent of homology was obtained by TF SEARCH ver. 1.3. Arrows indicate the characterized transcription initiation 
sites (arrow thickness is proportional to transcription start activity) [16]. The nucleotide deletions of reporter constructs are 
shown in grey.
xxxxxxTACGGAAAGGGGACAAAATCCACAGTGAAAGGCCTAGAAGCGGC
GCACTCCGCCCACGGGCGGCCCACGTGTCCACCTATTCCGCACCGCGCCC
TGTCCCATCCCTATGGAGCGGGGTCTGCCAACGCTCGCGAGAGCCCTCTC
GGCTTCCACGTTTGCCACGTTCCAAAGGACCGAGACAAACTGGAAAGCCG
AAAGAGGCTCGCGCTCACAGGCAGCTGCGTAGCGCCCGAACAGCCCTAAG
TGAGCAGGGGCGGGGAGCGCGGCAGGGTACCGCCGCCTCGTAAGGGCCCT
TGCGATTGGGTCCCAGGCGCCGTCACTCAGCCTTCCGGGGGCGGGGCGAG
GCCGGGAAGGGGCGTGGCCGTCGGGCGGCGAGCCGCGCGCTCTCGCCCCG
GGAGGGAGTCACAGGTTCGTACACGCGAGGCCGGGCGCGCGCAGCCGGCA
GGCGGGTGAAGTCTTCCCAGGTGCTGCAGGCGGTGCTGAGGCACAGGGTC
TGCTGCAGGAGCAGCGGCCCGAACCCGCTCCAGCGGCCCGCCGCCGCCAG
CGGTTCCCGCGTCGCGTGTGTACCCCCGCGCACTGAAGGAGGTCCGCCAG
CCCTCACCAGCCCCCGCGGACCGTGCAATG
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homologies to binding sites for USF1, Sp1 and for other
transcription factors. EMSA analyses demonstrated no
binding activity for these identified elements with the
exception of USF1 and Sp1 sites [16]. In the present study
we analyzed the DNA binding activity and function of
USF transcription factors on P1 promoter.
The first conclusion of this manuscript derives from EMSA
assays, supershift analysis and chromatin immunoprecip-
itation assays, which coherently demonstrated that USF1
and USF2 factors bind to the P1/USF site of the P1 pro-
moter, both in vitro (Figures 5) and in intact cells (Figure
6).
The second conclusion is the demonstration that these
interactions are functionally relevant for transcription effi-
ciency. The relevance of the USF binding for the transcrip-
tion regulation of the P1 promoter has been addressed by
two complementary approaches: (a) mutagenesis of the
P1/USF element and (b) use of a USF1 silencing
approach.
The results obtained concurrently demonstrate that USF
transcription factors and USF1 binding site are involved in
the up-regulation of the P1 promoter of the human AβH-
J-J gene locus. On the other hand, mutagenesis experi-
ments point out that the residual transcription activity of
the double mutant is compatible with the presence of
other transcription factors participating in the regulation
of the P1 promoter. This is in agreement with previously
published results from our group [16] demonstrating the
presence of at least 12 Sp binding sites and Sp1/3 depend-
ent transcription activity of P1 promoter. In addition, it is
in agreement with the experiments on progressively
deleted reporter constructs indicating that the decrease of
transcription associated with the -512/-389 deletion is
higher (Figure 3, – 42%) than that of the single mutant -
512 P1/USFmut construct with respect to the wild type
plasmid (Figure 7, – 21%). This evidence coherently sus-
tain the concept that other regulatory factors, in addition
to USF, are involved in P1 promoter directed transcription
of the AβH-J-J locus.
When the results presented here are taken together with
those recently published by Feriotto et al. [16], it appears
Table 1: Sequence of synthetic oligonucleotides used in this study
Double-stranded oligonucleotides used in gel shift assays and mutagenesysa
P1/USFmer 5'-GGCGGCCCACGTGTCCACCT-3'
USFmerb 5'-GGCCAGACCACGTGGTCTGTTC-3'
Sp1merb 5'-CCCTTGGTGGGGGCGGGGCCTAAGCTGCG-3'
MyoDmerc 5'-CCCCCCAACACCTGCTGCCTGA-3'
P1/USFmut 5'-CCCACGGGCGGCCACAGTGTCCACCTATTC-3'
P1/Spmut 5'-GTGAGCATAGTCGTAGAGCATGGTAGAGTACCGC-3'
Q-PCR Primers Amplified region Sequences
P1 ChIP f P1 promoter AβH-J-J 5'-AACGAACTAAATTCCTGCTTCAGC-3'
P1 ChIP r (contains USF elements) 5'-TCCTTTGGAACGTGGCAAACGT-3'
Neg ChIP f negative control region 5'-TGTGTGATTTCCCGTCAACTGTC-3'
Neg ChIP r (without USF elements) 5'-CCAGCCTCTTCCATTGGATACAA-3'
E1 f from exon 1 to 5 5'-CAAGAGCAGCGGCAACAG-3'
E5r of AβH-J-J transcripts 5'-AATAAAACTTTGGCATCATCCACTCAAAATCTCC-3'
qUSF1 f USF1 transcripts 5'-TGATGATGCAGTTGACACGGA-3'
qUSF1 r 5'-CAGTTGTTGATCTTGTCTCGGC-3'
GAPDH f glyceraldehyde-3-phosphate 5'-AAGGTCGGAGTCAACGGATTT-3'
GAPDH r dehydrogenase mRNA 5'-ACTGTGGTCATGAGTCCTTCCA-3'
HMBS f hydroxymethyl-bilane 5'-GAACATGCCCTGGAGAAGAATGA-3'
HMBS r synthase mRNA 5'-GGTAGCCTGCATGGTCTCTTGTAT-3'
ACTIN f actin mRNA 5'-TGACGGGGTCAACCACACTGTGCCCATCTA-3'
ACTIN r 5'-CTAGAAGCATTTGCGGTGGACGATGGAGGG-3'
a Nucleotide mutations are underlined; bThe oligonucleotide containing USF1 and Sp1sites were purchased from Geneka; c [14].BMC Molecular Biology 2008, 9:110 http://www.biomedcentral.com/1471-2199/9/110
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that both Sp and USF DNA interactions and transcription
activities are involved in the regulation of this human
locus [19-23].
Comparison of the P1 and P2 promoter sequences of the
AβH-J-J locus reveals important differences are clearly
detectable [15]. The most interesting result emerging from
studies focused on the P2 promoter is that the calcium-
dependent transcriptional factor MEF-2 activates the tran-
scription of junctin, junctate and AβH in striated muscles
and brain [14]. Neither Sp1 nor USF binding sites were
detected within the P2 promoter. On the other hand, P1
promoter, which drives the expression of AAH and hum-
bug in most tissues, contains one USF1 and several Sp1
functionally active binding sites within the sequence hav-
ing maximal transcription activity [15,16]. The finding
that the sequences present in the upstream P1 promoter
are significantly different from those of the P2 promoter
is, in our opinion, of great interest.
From the practical point of view, the impact of USF pro-
teins in the transcriptional regulation of this locus will be
of future interest considering the potential contribution of
AAH and humbug to the infiltrating growth of neoplasms
by increasing cell migration and enhancing proliferation
and survival [5-11]. For instance, overexpression of hum-
bug and AAH is associated with malignant progression in
human gastric cancer cells [24]. In addition, relevant to
our study, Xian et al. found that the protein expression
level of AAH in the hepatocellular carcinoma was parallel
with the mRNA expression level, indicating that the
expression is regulated at the transcription level [25]. Inhi-
bition of AAH and humbug transcription could represent
an attractive approach for gene therapy of infiltrating
tumors [3,5]. Of course, in discussing the possible impli-
Interaction of USF1 and USF2 transcription factors with the AβH-J-J P1 promoter Figure 5
Interaction of USF1 and USF2 transcription factors with the AβH-J-J P1 promoter. (A) EMSA were carried out on 
2 μg of Hela nuclear extracts as described in the Experimental procedures using P1/USFmer probe (Table 1). Probe was incu-
bated with nuclear extracts in the absence of competing oligonucleotides (lane 1) or in the presence of the indicated competing 
oligonucleotides (lanes 2–5). Arrows and asterisk indicate the specific and non-specific complexes respectively. (B) Supershift 
assay was performed using P1/USFmer probe and 2 μg of nuclear extract from HeLa cells; probe was incubated with nuclear 
exctract in the absence of antibody (lane 6) or in the presence of antibodies against USF1 factor, USF2 factor or both (lanes 7, 
8, and 9 respectively). Arrows indicate the specific complexes and arrowheads indicate the super-shifted complexes.
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cations of targeting mRNAs for USF transcription fac-
tor(s), careful considerations are required, due to a wide
involvement of this transcription factor in the regulation
of expression of several genes, including genes involved in
development and cell cycle progression [17].
Conclusion
When the results shown in the present paper are consid-
ered together with previously published reports by our
research group, it can be concluded that the AβH-J-J locus
contains at least two functionally distinct promoters (P1
Chromatin immunoprecipitation assay performed to evaluate in vivo USF interaction with P1 promoter Figure 6
Chromatin immunoprecipitation assay performed to evaluate in vivo USF interaction with P1 promoter. (A) 
Representative quantitative real-time PCR profiles for the amplification of the P1 promoter in the ChIP assay. USF1 ChIP, USF2 
ChIP and MEF-2A ChIP represents duplicate amplification curves from chromatin immunoprecipitated with USF1, USF2 or MEF-
2A antiserum respectively; nonimmune serum represent curves from immunoprecipitations with nonimmune rabbit serum. Input 
represents curves obtained from HeLa chromatin (1%) before immunoprecipitation. TF, threshold fluorescence. (B) In vivo 
association of USF1 and USF2 transcription factors with the AβH-J-J P1 promoter. The results, obtained from ChIP assay quan-
titative real time PCR using USF1 (USF1 ChIP) or USF2 (USF2 ChIP) antiserum, were analyzed following the methodology 
described in the methods section. The fold increase over negative control PCR in each case compares the values obtained by P1 
promoter amplification to the corresponding amplification of a distal genomic region lacking USF1 binding sites (Table 1). All 
data represent the mean of two separated PCR experiments each performed in triplicate, and obtained from at least two inde-
pendent immunoprecipitation. The asterisk indicates that the value is significantly different (p < 0,05) from the control value.
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Mutational analysis of USF elements in the AβH-J-J P1 promoter Figure 7
Mutational analysis of USF elements in the AβH-J-J P1 promoter. (A) EMSA were performed incubating P1/USFmer 
probe with 2 μg of nuclear extract from HeLa cells in the absence (lane 1) or in the presence of 100 fold molar excess of the 
indicated competing oligonucleotides (lanes 2–3). (B) USFmer probe was incubated with 2 μg of nuclear extract from HeLa 
cells in the absence (lane 4) or in the presence of 100 fold molar excess of the indicated competing oligonucleotides (lanes 5–
7) (Table 1). Arrows and asterisks indicate the specific and aspecific complexes respectively. (C) The reporter construct -512 
WT (H in Fig 3) was subjected to site directed mutagenesis in the sequence spanning Sp1 and USF binding sites. The constructs 
obtained were designated as -512 P1/Spmut and -512 P1/USFmut. In addition a double mutant containing both mutations was 
indicated as -512 P1/Sp+USFmut. HeLa cells transient transfection and luciferase assay were performed in two experiments 
conducted in triplicate and the data were normalized to Renilla luciferase activity and reported as ratios (means ± SD) to the 
wild type reporter construct -512 WT; *P < 0.05 and **P < 0.02.
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and P2), and multiple alternative splicing sites, leading to
the synthesis of the functionally distinct proteins, AAH,
humbug, junctin, and junctate [1,14-16]. The P1 pro-
moter directs AAH and humbug expression in most tis-
sues and is up-regulated by Sp and USF transcription
factors.
Methods
Cell Cultures
The human hepatoblastoma, HepG2, breast cancer, MCF7
and MDA-MB231, cervix epithelial carcinoma, HeLa, and
embryonic kidney, Hek293, were cultured in E-MEM
(Sigma, St. Louis, MO, USA) supplemented with 2 mM L-
glutamine (BioWhittaker, Walkersville, MD, USA) and 1
mM sodium pyruvate (Sigma); embryonic rhabdomyosa-
rcoma, RD cell line was cultured in D-MEM ((BioWhit-
taker) supplemented with 4 mM L-glutamine; melanoma,
Colo 38, cell line was cultured in RPMI 1640 (Sigma). All
cell lines were grown in a humidified atmosphere con-
taining 5% CO2 at 37°C in medium supplemented with
100 units/ml penicillin, 100 μg/ml streptomycin, and
10% (vol/vol) FBS.
Cell lines were all obtained from the ATCC (American
Type Culture Collection, Manassas, VA, USA).
RT-PCR Real-time
Total RNA was harvested from cell lines by using the TRI-
zol® Reagent (Invitrogen, Carlsbad, CA, USA). cDNA was
synthesized from 0.5 μg of total RNA using ImProm-II™
(Promega, Madison, WI, USA).
For quantitative real-time PCR reaction, 0,5/20 μl aliquots
of cDNA, 10 pmol of E1f and E5r primer (Table 1), 1 ×
iQ™ SYBR® Green Supermix (Bio-Rad, Hercules, CA, USA),
were used for each Sybr Green real-time PCR reaction to
quantitate the relative expression of P1 specific tran-
scripts. Primer E1f and E5r were designed to amplify a 297
bp sequence present in all the transcripts relative to P1
promoter activity and spanned intronic sequences in
order to rule out amplification from genomic DNA. Prim-
ers pairs and amplification conditions were validated by
melting curve and electhrophoretic analysis. Real-time
PCR reactions were performed for a total of 40 cycles
(95°C for 10 s, 65°C for 30 s, and 72°C for 50 s) using an
iCycler IQ® (Bio-Rad). The relative proportions of each
template amplified were determined by using IQ5 soft-
ware (Bio-Rad), employing the ΔΔCt method to compare
gene expression data. Each sample was quantitated in trip-
licate from at least two independent experiments. Mean ±
S.D. values were determined for each fold difference.
Amplification of human Actin, GAPDH and HMBS cDNA
has been used as internal standards (housekeeping
genes). Negative controls (no template cDNA) were also
run with every experimental plate to assess specificity and
to rule out contamination.
Transient transfection and dual luciferase assay
HeLa cells were transiently transfected with sequentially
deleted reporter constructs, obtained as previously
described [16], containing different regions of the -661/
+81 P1 nucleotide sequence cloned into pGL3-basic
reporter vector upstream firefly luciferase.
Cells were seeded at 70–80% confluence in 16-mm wells.
Transfection was performed after 24 hours using 1.2 μg of
Lipofectamine™ 2000 (Invitrogen), 30 ng pRL-TK vector
(Promega), which contains the Renilla luciferase gene as a
transfection efficiency control and 0.6 μg of Firefly luci-
ferase reporter plasmid per well. Lysates were prepared 48
h after transfection by adding 100 μl of passive lysis buffer
(Dual Luciferase® Reporter Assay System, Promega). Luci-
ferase activity was determined with an analytical lumi-
nometer (model TD-20/20, Turner Designs, Sunnyvale,
CA, USA); the light intensity produced by Firefly luciferase
(test plasmid) was normalized to that produced by Renilla
luciferase (control plasmid). Promoter activity was
Table 2: Double stranded oligonuleotides sequences inserted in shRNA vectors
USF1 shRNA
5'-TCGAGGTCGACAACAGGTGGAAGATTTCAAGAGAATCTTCCACCTGTTGTCGACTTTTTTACGCGTA-3'
3'-CCAGCTGTTGTCCACCTTCTAAAGTTCTCTTAGAAGGTGGACAACAGCTGAAAAAATGCGCATTCGA-5'
Scramble shRNA
5'-TCGAGGTACCGAACAACGCAACGAATTCAAGAGATTCGTTGCGTTGTTCGGTACTTTTTTACGCGTA-3'
3'-CCATGGCTTGTTGCGTTGCTTAAGTTCTCTAAGCAACGCAACAAGCCATGAAAAAATGCGCATTCGA-5'
The 19 base pair oligonucleotides specific for USF1 siRNA or containing scambled sequences are underlined; XhoI and HindIII cloning sites are in 
italic.BMC Molecular Biology 2008, 9:110 http://www.biomedcentral.com/1471-2199/9/110
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Effect of USF1 silencing obtained by short interference RNA on P1 promoter activity Figure 8
Effect of USF1 silencing obtained by short interference RNA on P1 promoter activity. HeLa cells were transiently 
transfected with USF1 shRNA vector, with Scramble shRNA vector or vector in which no small hairpin DNA oligo was cloned 
(Null shRNA vector). Two days after transient transfection of these vectors into HeLa cells, total RNA was extracted and used 
for quantitative Real Time RT-PCR, using primers targeting USF1 mRNA (panel A) or P1 promoter specific transcripts (panel 
B). Results represent the average ± SD of three independent experiments carried out in duplicate; ΔΔCt method was used to 
compare gene expression data, standard error of the mean was calculated; statistical significance: *P < 0.05.
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expressed as fold induction relative to that of cells trans-
fected with pGL3-basic vector [16].
Nuclear extract preparation
Nuclear extracts were prepared as described by Andrews
and Faller [26]. Briefly, cells were collected, washed twice
with ice-cold phosphate-buffered saline, and resuspended
in 0.4 ml/107 cells of hypotonic lysis buffer (10 mM
Hepes/KOH, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM
dithiothreitol, and 0.2 mM phenylmethanesulfonyl fluo-
ride). After incubation on ice for 10 min, the mixture were
vortexed for 10 seconds, and nuclei were pelleted by cen-
trifugation at 12000 g for 10 seconds, then nuclear pro-
teins were extracted by incubation of the nuclei for 20 min
on ice with intermittent gentle vortexing in 20 mM Hepes/
KOH, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.2 mM
phenylmethanesulfonyl fluoride, 1 μg·mL-1 aprotinin, 1
μg·mL-1  leupeptin, 2 mM Na3VO4, and 10 mM NaF
(Sigma, St Louis, MO, USA); cell debris was removed by
centrifugation at 12000 g for 5 min at 4°C. The Bradford
method was used to measure the protein concentration in
the extract, which was then stored in aliquots at -80°C.
Electrophoretic mobility shift assays
The double-stranded oligonucleotides (ODN) used in the
EMSA are reported in Table 1. 3 pmol of ODN were 32P-
labeled using OptiKinase (GE Healthcare, Chalfont St
Giles, UK), annealed to an excess of complementary ODN
and purified from [γ-32P]ATP (Perkin Elmer, Wellesley,
MA, USA). Binding reactions were performed by incubat-
ing 2 μg of nuclear extract and 16 fmol of 32P-labeled dou-
ble-stranded ODN, with or without competitor in a final
volume of 20 μL of binding buffer (20 mM Tris-HCl, pH
7.5, 50 mM KCl, 1 mM MgCl2, 0.2 mM EDTA, 5% glyc-
erol, 1 mM dithiothreitol, 0.01% TritonX100, 0.05 μg·μL-
1 of poly dI-dC, 0.05 μg·μL-1 of a single-stranded ODN)
[14]. Competitor (100 fold excess of unlabeled ODNs)
and nuclear extract mixture were incubated for 15 min
and then probe was added to the reaction. After a further
incubation of 30 min at room temperature samples were
immediately loaded onto a 6% nondenaturing polyacry-
lamide gel containing 0.25 × Tris/borate/EDTA (22.5 mM
Tris, 22.5 mM boric acid, 0.5 mM EDTA, pH 8) buffer.
Electrophoresis was carried out at 200 V. Gels were vac-
uum heat-dried and subjected to autoradiography. Super-
shift assays were performed as described previously [16]
by using 2 μg of commercially available antibodies spe-
cific for USF1 (sc-229X) and USF2 (sc-862X) transcription
factors (Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA).
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation assays were performed
by using the Chromatin Immunoprecipitation Assay Kit
(Upstate Biotechnology Inc., Lake Placid, NY, USA).
Briefly, a total of 6 × 107 HeLa cells (from 5 15-cm plates)
were treated, for 10 min at room temperature, with 1%
formaldehyde culture medium. Cells were washed in
phosphate-buffered saline, and then glycine was added to
a final concentration of 0.125 M. The cells were then sus-
pended in 1.5 ml of lysis buffer (1% SDS, 10 mM EDTA,
and 50 mM Tris-Cl, pH 8.1) plus protease inhibitors (1
μg/ml pepstatin A, 1 μg/ml leupeptin, 1 μg/ml aprotinin,
and 1 mM phenylmethylsulfonyl fluoride) and the chro-
matin subjected to sonication (using a Sonics Vibracell
VC130 sonicator with a 2-mm probe). Fifteen 15-s sonica-
tion pulses at 30% amplitude were required to shear chro-
matin to 200–1000 bp fragments. 0.2-ml aliquots of
chromatin were diluted to 2 ml in ChIP dilution buffer
containing protease inhibitors and then cleared with 75 μl
of salmon sperm DNA/protein A-agarose 50% gel slurry
(Upstate Biotechnology) for 1 h at 4°C before incubation
on a rocking platform with either 6–10 μg of specific
antiserum USF1, USF2, and MEF-2A (Santa Cruz Biotech-
nology) or normal rabbit serum (Upstate Biotechnology).
20 μl of diluted chromatin was saved and stored for later
PCR analysis as 1% of the input extract). Incubations
occurred overnight at 4°C and continued an additional 1
h after the addition of 60 μl protein A-agarose slurry.
Thereafter the agarose pellets were washed consecutively
with low salt, high salt and LiCl buffers. DNA/protein
complexes were recovered from the pellets with elution
buffer (0.1 M NaHCO3 with 1% SDS), and cross-links
were reversed by incubating overnight at 65°C with 0.2 M
NaCl. The samples were treated with RNase A and protei-
nase K, extracted with phenol/chloroform and ethanol-
precipitated. The pelletted DNAs were washed with 70%
ethanol and dissolved in 40 μl of Tris/EDTA. 2 μl aliquots
were used for each real-time PCR reaction to quantitate
immunoprecipitated promoter fragments.
Real-time PCR Quantitation of Immunoprecipitated 
Promoter Fragments
For quantitative real-time PCR reaction conditions each
25  μl reaction contained 2 μl of template DNA (from
chromatin immunoprecipitations), 10 pmol of primers
(Table 1) and 1 × iQ™ SYBR® Green Supermix (Bio-Rad).
Real-time PCR reactions were performed for a total of 40
cycles (97°C for 15 s, 65°C for 30 s, and 72°C for 30 s)
using an iCycler IQ® (Bio-Rad). The relative proportions of
immunoprecipitated promoter fragments were deter-
mined based on the threshold cycle (Tc) value for each
PCR reaction. Real time PCR data analysis followed the
methodology previously described [27,28]. A ΔTC value
was calculated for each sample by subtracting the Tc value
for the input (to account for differences in amplification
efficiencies and DNA quantities before immunoprecipita-
tion) from the Tc value obtained for the immunoprecipi-
tated sample. A ΔΔTc  value was then calculated byBMC Molecular Biology 2008, 9:110 http://www.biomedcentral.com/1471-2199/9/110
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subtracting the ΔTc value for the sample immunoprecipi-
tated with specific antiserum from the ΔTc value for the
corresponding control sample immunoprecipitated with
nonimmune rabbit serum. Fold differences (specific
antiserum ChIP relative to nonimmune serum control
ChIP) were then determined by raising 2 to the ΔΔTC
power. PCR was also performed using control primers
that amplify a 197 bp genomic region lacking USF1 bind-
ing sites. The ΔΔTc values were then calculated as previ-
ously described and the negative control PCR data were
used to normalize quantitative results from different
immunoprecipitation. Each sample was quantitated in
triplicate on at least two separate experiments and from at
least two independent immunoprecipitations. Mean ±
S.D. values were determined for each fold difference.
Site-directed mutagenesis
Mutagenesis was performed by using a QuickChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA, USA).
Two double stranded mutant oligonucleotides (P1/Spmut
and P1/USFmut plus the flanking 9–12 mer of P1 nucle-
otide sequence (Table 1) were used to inactivate specific
binding in the pGL3 construct containing the -512/+81
promoter sequence. The nucleotide sequence of the
mutant constructs was confirmed by DNA sequencing.
USF1-targeted shRNA plasmid construction and 
transfection in HeLa cells
The effect of USF1 on P1 promoter directed expression
was evaluated by RNA interference approach using the
Knockout™ Single Vector Inducible RNAi System (Clon-
tech, Mountain View, CA, USA). siRNA targeting USF1
mRNA (GenBank accession n° NM_007122) were
designed by using the siRNA-sequence designer software
(Clontech). We produced a double strand oligonucleotide
for shRNA plasmid construction containing from 5' to 3'
end: XhoI cloning site, a guanine residue, the 19 base pair
target specific sense strand followed by a short spacer
(TTCAAGAGA), the reverse complement of the sense
strand, six thymidines, as an RNA polymerase III tran-
scription stop signal, a HindIII cloning site (Table 2). This
oligonucleotide was cloned into XhoI-HindIII site of the
pSingle-tTS-shRNA Vector (Clontech), in which shRNA is
expressed under the control of the U6 promoter. A nega-
tive control scrambled siRNA, which had no significant
homology to human gene and transcript sequences, was
designed to detect any non specific effects.
After cloning and sequence characterization, 500 ng of
plasmids were transfected into HeLa cells using Lipo-
fectamine™ 2000 (Invitrogen), and, after 8 hours, 20 ng/
ml of doxycycline were added. Fourty-eight hours later
RNA extraction and reverse transcription were performed.
To quantitate the depletion of USF1 and AβH-J-J P1
directed transcripts, 1/20 μl aliquots of cDNA and 10
pmol of the primers reported in table 1 were used for each
Sybr Green real-time PCR reaction. Resuls were normal-
ized with glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and hydroxymethylbilane synthase (HMBS)
expression levels (housekeeping genes). Real-time PCR
reactions were performed for a total of 40 cycles (95°C for
10 s, 66°C for 30 s, and 72°C for 50 s). The ΔΔCt method
was used to compare gene expression data.
Statistical analysis
All the data were normally distributed and presented as
mean ± S.D. Statistical differences between groups were
compared using one-way ANOVA (ANalyses Of VAriance
between groups) software. Statistical significance was
assumed at p < 0.05.
List of abbreviations
AAH: aspartyl (asparaginyl) β-hydroxylase; PCR(s):
polymerase chain reaction(s); bp: base pair(s); MEF-2:
myocyte enhancer factor 2; USF: Upstream Stimulatory
Factor; Sp: specific transcription factor; EMSA: electro-
phoretic mobility shift assay; ChIP: chromatin immuno-
precipitation; siRNA: short interference RNA; shRNA:
short hairpin RNA.
Authors' contributions
AF planned and performed all the experiments and partic-
ipated in the design and writing of the manuscript. ST col-
laborated in mutant reporter vectors design, production,
and validation. FZ participated in the P1 reporter con-
structs production and contributed to the transfection
experiments. RG participated in the analysis of the results
and critically reviewed the manuscript. GF designed the
study, supervised the experiments and wrote the manu-
script. All authors read and approved the final manu-
script.
Acknowledgements
Our paper is dedicated to the memory of Professor Stefano Ferrari. This 
work was supported by grants from FIRB, Ministero Università e Ricerca 
Scientifica e Tecnologica 60 and 40%, the Department of Anesthesia Kan-
tosspital Basel, HPRN-CT-2002-00331 from the European Union, Italian 
Space Agency and Swiss Muscle Foundation. R.G. is supported by grants 
from AIRC, COFIN-2004, FIRB.
References
1. Treves S, Feriotto G, Moccagatta L, Gambari R, Zorzato F: Molecu-
lar cloning, expression, functional characterization, chromo-
somal localization, and gene structure of junctate, a novel
integral calcium binding protein of sarco(endo)plasmic retic-
ulum membrane.  J Biol Chem 2000, 275:39555-39568.
2. Dinchuk JE, Henderson NL, Burn TC, Huber R, Ho SP, Link J, O'Neil
KT, Focht RJ, Scully MS, Hollis JM, Hollis GF, Friedman PA: Aspartyl
beta-hydroxylase (Asph) and an evolutionarily conserved
isoform of Asph missing the catalytic domain share exons
with junctin.  J Biol Chem 2000, 275:39543-39554.
3. Maeda T, Sepe P, Lahousse S, Tamaki S, Enjoji M, Wands JR, de la
Monte SM: Antisense oligodeoxynucleotides directed against
aspartyl (asparaginyl) beta-hydroxylase suppress migration
of cholangiocarcinoma cells.  J Hepatol 2003, 38(5):615-622.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Molecular Biology 2008, 9:110 http://www.biomedcentral.com/1471-2199/9/110
Page 15 of 15
(page number not for citation purposes)
4. Gundogan F, Elwood G, Greco D, Rubin LP, Pinar H, Carlson RI,
Wands JR, de la Monte SM: Role of aspartyl-(asparaginyl) beta-
hydroxylase in placental implantation: Relevance to early
pregnancy loss.  Hum Pathol 2007, 38:50-59.
5. Ho SP, Scully MS, Krauthauser CM, Wexler EJ, Stow MD, Dinchuk JE,
Kerr JS, Friedman PA: Antisense oligonucleotides selectively
regulate aspartyl beta-hydroxylase and its truncated protein
isoform in vitro but distribute poorly into A549 tumors in
vivo.  J Pharmacol Exp Ther 2002, 302:795-803.
6. Wang J, de la Monte SM, Sabo E, Kethu S, Tavares R, Branda M, Simao
L, Wands JR, Resnick MB: Prognostic value of humbug gene
overexpression in stage II colon cancer.  Hum Pathol 2007,
38:17-25.
7. Ince N, de la Monte SM, Wands JR: Overexpression of human
aspartyl (asparaginyl) beta-hydroxylase is associated with
malignant transformation.  Cancer Res 2000, 60:1261-1266.
8. Sepe PS, Lahousse SA, Gemelli B, Chang H, Maeda T, Wands JR, de la
Monte SM: Role of the aspartyl-asparaginyl-beta-hydroxylase
gene in neuroblastoma cell motility.  Lab Invest 2002,
82:881-891.
9. Palumbo KS, Wands JR, Safran H, King T, Carlson RI, de la Monte SM:
Human aspartyl (asparaginyl) beta-hydroxylase monoclonal
antibodies: potential biomarkers for pancreatic carcinoma.
Pancreas 2002, 25:39-44.
10. Maeda T, Taguchi K, Aishima S, Shimada M, Hintz D, Larusso N,
Gores G, Tsuneyoshi M, Sugimachi K, Wands JR, de la Monte SM:
Clinicopathological correlates of aspartyl (asparaginyl) beta-
hydroxylase over-expression in cholangiocarcinoma.  Cancer
Detect Prev 2004, 28:313-318.
11. de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M,
Carter JJ, Lahousse SA, Califano S, Maeda T, Ueno T, D'Errico A, Tre-
visani F, Wands JR: Aspartyl-(asparaginyl)-beta-hydroxylase
regulates hepatocellular carcinoma invasiveness.  J Hepatol
2006, 44:971-983.
12. Treves S, Franzini-Armstrong C, Moccagatta L, Arnoult C, Grasso C,
Schrum A, Ducreux S, Zhu MX, Mikoshiba K, Girard T, Smida-Rezgui
S, Ronjat M, Zorzato F: Junctate is a key element in calcium
entry induced by activation of InsP3 receptors and/or cal-
cium store depletion.  J Cell Biol 2004, 166:537-548.
13. Stamboulian S, Moutin MJ, Treves S, Pochon N, Grunwald D, Zorzato
F, De Waard M, Ronjat M, Arnoult C: Junctate, an inositol 1,4,5-
triphosphate receptor associated protein, is present in
rodent sperm and binds TRPC2 and TRPC5 but not TRPC1
channels.  Dev Biol 2005, 286:326-337.
14. Feriotto G, Finotti A, Volpe P, Treves S, Ferrari S, Angelelli C, Zor-
zato F, Gambari R: Myocyte enhancer factor 2 activates pro-
moter sequences of the human AbetaH-J-J locus, encoding
aspartyl-beta-hydroxylase, junctin, and junctate.  Mol Cell Biol
2005, 25:3261-3275.
15. Feriotto G, Finotti A, Breveglieri G, Treves S, Zorzato F, Gambari R:
Multiple levels of control of the expression of the human
AbetaH-J-J locus encoding aspartyl-beta-hydroxylase, junc-
tin, and junctate.  Ann N Y Acad Sci 2006, 1091:184-190.
16. Feriotto G, Finotti A, Breveglieri G, Treves S, Zorzato F, Gambari R:
Transcriptional activity and Sp 1/3 transcription factor bind-
ing to the P1 promoter sequences of the human AbetaH-J-J
locus.  FEBS J 2007, 274:4476-4490.
17. Corre S, Galibert MD: Upstream stimulating factors: highly
versatile stress-responsive transcription factors.  Pigment Cell
Res 2005, 18:337-348.
18. Gongora C, Degols G, Espert L, Hua TD, Mechti N: A unique ISRE,
in the TATA-less human Isg20 promoter, confers IRF-1-
mediated responsiveness to both interferon type I and type
II.  Nucleic Acids Res 2000, 28:2333-2341.
19. Ge Y, Konrad MA, Matherly LH, Taub JW: Transcriptional regula-
tion of the human cystathionine beta-synthase -1b basal pro-
moter: synergistic transactivation by transcription factors
NF-Y and Sp1/Sp3.  Biochem J 2001, 357:97-105.
20. Liu M, Whetstine JR, Payton SG, Ge Y, Flatley RM, Matherly LH:
Roles of USF, Ikaros and Sp proteins in the transcriptional
regulation of the human reduced folate carrier B promoter.
Biochem J 2004, 383:249-257.
21. Ge Y, Jensen TL, Matherly LH, Taub JW: Physical and functional
interactions between USF and Sp1 proteins regulate human
deoxycytidine kinase promoter activity.  J Biol Chem 2003,
278:49901-49910.
22. Kim SY, Choi SY, Chao W, Volsky DJ: Transcriptional regulation
of human excitatory amino acid transporter 1 (EAAT1):
cloning of the EAAT1 promoter and characterization of its
basal and inducible activity in human astrocytes.  J Neurochem
2003, 87:1485-1498.
23. Pagliuca A, Cannada-Bartoli P, Lania L: A role for Sp and helix-
loop-helix transcription factors in the regulation of the
human Id4 gene promoter activity.  J Biol Chem 1998,
273:7668-7674.
24. Lee JH: Overexpression of humbug promotes malignant pro-
gression in human gastric cancer cells.  Oncol Rep 2008,
19:795-800.
25. Xian ZH, Zhang SH, Cong WM, Yan HX, Wang K, Wu MC: Expres-
sion of aspartyl beta-hydroxylase and its clinicopathological
significance in hepatocellular carcinoma.  Mod Pathos 2006,
19:280-286.
26. Andrews NC, Faller DV: A rapid micropreparation technique
for extraction of DNA-binding proteins from limiting num-
bers of mammalian cells.  Nucleic Acids Res 1991, 19:2499.
27. Chakrabarti SK, James JC, Mirmira RG: Quantitative assessment
of gene targeting in vitro and in vivo by the pancreatic tran-
scription factor, Pdx1. Importance of chromatin structure in
directing promoter binding.  J Biol Chem 2002, 277:13286-13293.
28. Christenson LK, Stouffer RL, Strauss III JF: Quantitative analysis of
the hormone-induced hyperacetylation of histone H3 associ-
ated with the steroidogenic acute regulatory protein gene
promoter.  J Biol Chem 2001, 276:27392-27399.